Navigation Links
Surgery without stitches

A thin polymer bio-film that seals surgical wounds could make sutures a relic of medical history.

Measuring just 50 microns thick, the film is placed on a surgical wound and exposed to an infrared laser, which heats the film just enough to meld it and the tissue, thus perfectly sealing the wound.

Known as Surgilux, the devices raw material is extracted from crab shells and has Food and Drug Administration approval in the US.

Early test results indicate that it has strongest potential for use in brain and nerve surgery because it can avoid the numerous disadvantages of invasive stictches/sutures, which fail to seal and can act as a source of infection.

Up to 11% of brain surgery patients have to return for repeat surgery due to leakage of cerebro-spinal fluid (CSF) and other complications arising from sutures.

Surgical sutures date back some 4,000 years, so a new approach is long overdue, according to one of the devices inventors and leader of the Bio/polymer Research Group, UNSW scientist John Foster.

Others have tried surgical glues but these are mainly gel-like so bonding to the tissue is uneven often resulting in leakages and theyre not easy to use. The strongest surgical glue is so toxic that its limited to external applications, says Dr Foster. Other devices use ultra-violet light to effect rather poor sealing, but UV rays are damaging to living cells

The beauty of this is that infra-red laser doesnt cause any tissue damage. Better still, Surgilux has anti-microbial properties, which deters post-operative infections.

Foster and his team are working with micro-surgeon Marcus Stoodley who specialises in nerve repair. Based at the Prince of Wales Hospital Stoodley is excited about early test results.

Surgilux is well suited to repairing damaged nerves because the gold standard -- sutures inevitably cause damage to nerves and there is always some permanent loss of function.

Our test results with rats have shown some degree of permanent nerve recovery within six weeks of operating.

The researchers who are looking for commercial backing to initiate clinical trials are planning a second generation version of Surgilux that incorporates growth factors and perhaps stem cells to regenerate nerves.


Contact: Dan Gaffney
University of New South Wales

Related biology news :

1. Minimally invasive heart surgery research wins NIH award
2. Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery
3. BMI criteria for obesity surgery should be lowered, UT Southwestern researcher suggests
4. Neuronal conduction of excitation without action potentials based on ceramide production
5. The benefits of 80 million years without sex
6. Coral reefs will be permanently damaged without urgent action
Post Your Comments:
(Date:10/29/2015)... , Oct. 29, 2015   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... High Tech Association (MHTA) as one of only three ... the "Software – Small and Growing" category. The Tekne Awards ... who have shown superior technology innovation and leadership. ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
(Date:10/29/2015)... , Oct. 29, 2015 Today, ... a partnership with 2XU, a global leader in ... a smart hat with advanced bio-sensing technology. The ... athletes to monitor key biometrics to improve overall ... partnership, the two companies will bring together the most ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , November 26, 2015 ... Biobanking Market 2016 - 2020 report analyzes that ... integrity and quality in long-term samples, minimizing manual ... cost-effectiveness. Automation minimizes manual errors such as mislabeling ... efficiency. Further, it plays a vital role in ...
(Date:11/25/2015)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today ... Neurocrine Biosciences, will be presenting at the 27th Annual ... . .   Listeners ... prior to the presentation to download or install any ... available on the website approximately one hour after the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or "the ... results for the quarter ended September 30, 2015. ... dollars and presented under International Financial Reporting Standards ... ," said Andrew Rae , President & ... are not only value enriching for this clinical ...
Breaking Biology Technology: